NCT02046902

Brief Summary

The goal of this study is to gather input from patients who have undergone PCI, their family and/or caregivers, and clinicians to develop a patient decision aid. The purpose of the decision aid is to deliver information, including individualized estimates of patients' restenosis risk, in an understandable format that would be informative and assist in decision-making for patients undergoing PCI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
586

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2014

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 28, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

July 24, 2019

Completed
Last Updated

August 6, 2019

Status Verified

July 1, 2019

Enrollment Period

2.3 years

First QC Date

January 22, 2014

Results QC Date

April 19, 2018

Last Update Submit

July 26, 2019

Conditions

Keywords

coronary artery diseasecardiac stentPCI procedurePatient preference

Outcome Measures

Primary Outcomes (1)

  • Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching

    The primary outcome was whether or not patients participated in SDM regarding stent choice. Patients were categorized as having participated in SDM if they answered anything other than "doctor alone" in response to the question "Who chose the type of stent?"

    30 months

Secondary Outcomes (1)

  • Concordance Between Stent Preference and Stent Received Was a Secondary Outcome.

    30 months

Study Arms (2)

Heart disease

Adults with a diagnosis of coronary artery disease and may have had a percutaneous coronary intervention.

Healthy adults

Adults without a diagnosis of coronary artery disease. Focus groups will be held.

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults with and without coronary artery disease

You may qualify if:

  • \>18 years old
  • English or Spanish speaking
  • Presence of coronary disease, or a caregiver/relative of one with coronary disease

You may not qualify if:

  • non-English or non-Spanish speaking
  • dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Truman Medical Center

Kansas City, Missouri, 64108, United States

Location

Saint Luke's Hospital of Kansas City

Kansas City, Missouri, 64111, United States

Location

Related Publications (2)

  • Chhatriwalla AK, Decker C, Gialde E, Catley D, Goggin K, Jaschke K, Jones P, deBronkart D, Sun T, Spertus JA. Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design. Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005139. doi: 10.1161/CIRCOUTCOMES.118.005139.

  • Qintar M, Chhatriwalla AK, Arnold SV, Tang F, Buchanan DM, Shafiq A, Pokharel Y, deBronkart D, Ashraf JM, Spertus JA. Beyond restenosis: Patients' preference for drug eluting or bare metal stents. Catheter Cardiovasc Interv. 2017 Sep 1;90(3):357-363. doi: 10.1002/ccd.26946. Epub 2017 Feb 7.

MeSH Terms

Conditions

Heart DiseasesCoronary Artery DiseasePatient Preference

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesCoronary DiseaseMyocardial IschemiaArteriosclerosisArterial Occlusive DiseasesVascular DiseasesPatient SatisfactionTreatment Adherence and ComplianceHealth BehaviorBehavior

Limitations and Caveats

The lack of randomization, availability of ePrism at hospitals, estimation of TVR risk in the SDM tool without the availability of angiographic data, and physicians were not surveyed for additional variables that impacted their stent selection.

Results Point of Contact

Title
Carole Decker
Organization
Saint Luke's Mid America Heart Institute

Study Officials

  • John A Spertus, MD, MPH

    University of Missouri, Kansas City

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Daniel Lauer/Missouri Endowed Chair

Study Record Dates

First Submitted

January 22, 2014

First Posted

January 28, 2014

Study Start

September 1, 2014

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

August 6, 2019

Results First Posted

July 24, 2019

Record last verified: 2019-07

Locations